TREM2 and Alzheimer disease: For example, CSF pQTL analyses performed by Deming et al. showed that a genetic variant near MS4A6A and MS4A4A, associated with increased AD risk, was identified as a trans-pQTL that reduces soluble TREM2 levels in CSF [192].